Lin Shao-Lee (CIK 1725092) reported 8 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-08-14). Recent activity: Buy CUE (109,179 shares), Sell CUE (34,225 shares), Sell CUE (5,775 shares), Sell CUE (5,423 shares), Sell CUE (2,375 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-14 | Cue Biopharma, Inc. (CUE) | Chief Executive Officer | Buy | 109,179 | $0 |
| 2026-08-14 | Cue Biopharma, Inc. (CUE) | Chief Executive Officer | Sell | 34,225 | $923,733 |
| 2026-08-14 | Cue Biopharma, Inc. (CUE) | Chief Executive Officer | Sell | 5,775 | $160,256 |
| 2026-08-14 | Cue Biopharma, Inc. (CUE) | Chief Executive Officer | Sell | 5,423 | $147,451 |
| 2026-08-14 | Cue Biopharma, Inc. (CUE) | Chief Executive Officer | Sell | 2,375 | $66,761 |
| 2026-08-14 | Cue Biopharma, Inc. (CUE) | Chief Executive Officer | Sell | 10,460 | $308,361 |
| 2026-07-10 | Cue Biopharma, Inc. (CUE) | Chief Executive Officer | Buy | 327,537 | $0 |
| 2026-05-07 | Cue Biopharma, Inc. (CUE) | CHIEF EXECUTIVE OFFICER | Buy | 327,537 | $0 |
Source: SEC Form 4 filings · as of 2026-08-14